Potently neutralizing and protective human antibodies against SARS-CoV-2

Seth J. Zost; Pavlo Gilchuk; James Brett Case; Elad Binshtein; Rita E. Chen; Joseph P. Nkolola; Alexandra Schäfer; Joseph X. Reidy; Andrew Trivette; Rachel S. Nargi; Rachel E. Sutton; Naveenchandra Suryadevara; David R. Martinez; Lauren E. Williamson; Elaine C. Chen; Taylor Jones; Samuel B. Day; Luke Myers; Ahmed O. Hassan; Natasha M. Kafai; Emma S. Winkler; Julie M. Fox; Swathi Shrihari; Benjamin K. Mueller; Jens Meiler; Abishek Chandrashekar; Noe B. Mercado; James J. Steinhardt; Kuishu Ren; Yueh–Ming Loo; Nicole L. Kallewaard; Broc T. McCune; Shamus P. Keeler; Michael J. Holtzman; Dan H. Barouch; Lisa E. Gralinski; Ralph S. Baric; Larissa B. Thackray; Michael Diamond; Robert H. Carnahan; James E. Crowe

doi:10.1038/s41586-020-2548-6

Keywords

Monoclonal antibodyEpitopeAntibodyVirologyNeutralizing antibodyImmunologyMedicineBiology

Affiliated Institutions

Related Publications

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. García-Beltrán , Evan C. Lam , Kerri St. Denis +12 more

Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spi...

2021 Cell 1520 citations

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian , Cheng Li , Ailing Huang +8 more

The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human...

2020 Emerging Microbes & Infections 1257 citations

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian , Cheng Li , Ailing Huang +8 more

ABSTRACT The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 800 laboratory-confirmed human infections, including 25 deaths, posing a serious threat to ...

2020 bioRxiv (Cold Spring Harbor Laboratory) 187 citations

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers , Fangzhu Zhao , Deli Huang +31 more

Protective neutralizing antibodies Antibodies produced by survivors of coronavirus disease 2019 (COVID-19) may be leveraged to develop therapies. A first step is identifying neu...

2020 Science 1467 citations

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

Mimi Guebre‐Xabier , Nita Patel , Jing-Hui Tian +10 more

There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective effi...

2020 Vaccine 238 citations

Publication Info

Year: 2020
Type: article
Volume: 584
Issue: 7821
Pages: 443-449
Citations: 1166
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Potently neutralizing and protective human antibodies against SARS-CoV-2

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1166

OpenAlex

Cite This

APA Style

                            
                                
                                    Seth J. Zost, 
                                
                                    Pavlo Gilchuk, 
                                
                                    James Brett Case
                                
                                et al.
                            
                            (2020). 
                            Potently neutralizing and protective human antibodies against SARS-CoV-2. 
                            Nature
                            , 584
                            (7821)
                            , 443-449.
                            https://doi.org/10.1038/s41586-020-2548-6
                        

Identifiers

DOI: 10.1038/s41586-020-2548-6